baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Provectus Biopharmaceuticals, Inc.../ US74373P1084 /

2024-05-21 9:18:06 PM	Chg. 0.0000	Volume	Bid-	Ask-	High	Low
0.1900USD	0.00%	186,972 Turnover: 35,478.3000	-Bid Size: -	-Ask Size: -	0.1900	0.1881

GlobeNewswire 05-21 Provectus Biopharmaceuticals Announces Poster Presentation of Rose Bengal Sodium for Treatment of Fu...

GlobeNewswire 05-14 Provectus Biopharmaceuticals Announces Eight Presentations of Rose Bengal Photodynamic Antimicrobial...

GlobeNewswire 05-02 Provectus Biopharmaceuticals Announces Notice of Allowance for U.S. Patent of Oral Administration of...

GlobeNewswire 04-18 Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Pro...

GlobeNewswire 04-16 Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder...

GlobeNewswire 04-11 Provectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC a...

GlobeNewswire 03-27 Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miam...

GlobeNewswire 03-12 Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Benga...

GlobeNewswire 03-07 Provectus Biopharmaceuticals Announces Acceptance of Cancer Immunotherapy PV-10 Abstract for HNSCC a...

GlobeNewswire 02-29 Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstrac...

GlobeNewswire 02-15 Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call

GlobeNewswire 02-14 Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services

GlobeNewswire 2023-12-18 Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodiu...

GlobeNewswire 2023-11-15 Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Advanced Cutane...

GlobeNewswire 2023-11-13 Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uvea...

GlobeNewswire 2023-11-06 Provectus Biopharmaceuticals Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data at So...

GlobeNewswire 2022-03-24 Provectus Biopharmaceuticals Announces Synthesis of New Halogenated Xanthene Small Molecule

GlobeNewswire 2022-02-16 Provectus Biopharmaceuticals Announces Acceptance of PV-10® Metastatic Uveal Melanoma Abstract for O...

GlobeNewswire 2022-02-08 Provectus Biopharmaceuticals Announces Acceptance of PV-10® Systemic Administration Abstract at Amer...

GlobeNewswire 2022-01-27 Provectus Biopharmaceuticals Provides Update on Research into PV-10® Immunotherapy as an Immune Adju...

GlobeNewswire 2022-01-10 Provectus Biopharmaceuticals Announces Publication of Pharmaceutical-Grade Rose Bengal’s Activity Ag...

GlobeNewswire 2021-11-01 Provectus Biopharmaceuticals Announces Presentation of Meta-Analysis Results of Single-Agent PV-10® ...

GlobeNewswire 2021-10-28 Provectus Biopharmaceuticals Announces Presentation of Updated Data from Combination Therapy Trial o...

GlobeNewswire 2021-10-04 Provectus Biopharmaceuticals Provides Update on Research into Oral Administration of PV-10® Immunoth...

GlobeNewswire 2021-09-27 Provectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentations at Society for Melan...

Provectus Biopharmaceuticals, Inc.../ US74373P1084 /

If you wish to receive reply to your feedback, please provide your email address.